Trevi Therapeutics (NASDAQ: TRVI) net income
Trevi Therapeutics reported a net loss of $42.8m for fiscal 2025; in fiscal 2024 it reported a net loss of $47.9m. Earnings per share were −$0.32.
Trevi Therapeutics's best year of the last 8 was fiscal 2018. It reported a loss in 8 of those 8 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$42.8m | — | — | −$0.32 |
| 2024 | −$47.9m | — | — | −$0.47 |
| 2023 | −$29.1m | — | — | −$0.29 |
| 2022 | −$29.2m | — | — | −$0.45 |
| 2021 | −$33.9m | — | — | −$1.49 |
| 2020 | −$32.8m | — | — | — |
| 2019 | −$26.1m | — | — | — |
| 2018 | −$20.5m | — | — | — |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Trevi Therapeutics net income compared with its sector
By net income for its latest fiscal year, Trevi Therapeutics ranks 244th of the 501 US health care companies with a page on Celsmar.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 242nd | OrthoPediatrics | −$39.6m | −16.8% |
| 243rd | Palvella Therapeutics | −$41.7m | — |
| 244th | Trevi Therapeutics | −$42.8m | — |
| 245th | 10x Genomics | −$43.5m | −6.8% |
| 246th | Codexis | −$44.0m | −62.5% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Trevi Therapeutics
- How much did Trevi Therapeutics earn in fiscal 2025?
- Trevi Therapeutics reported a net loss of $42.8m for fiscal 2025. In fiscal 2024 it reported a net loss of $47.9m.
- What are the earnings per share of Trevi Therapeutics?
- They were −$0.32 in fiscal 2025, compared with −$0.47 in fiscal 2024.
- Where does Trevi Therapeutics rank in its sector by net income?
- It ranks 244th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Trevi Therapeutics come from?
- From the annual report (Form 10-K) that Trevi Therapeutics files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Trevi Therapeutics files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018. More on Trevi Therapeutics: the Trevi Therapeutics page · annual accounts · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.